Management of FLT3-Mutated AML: What’s New in 2026?
Virtual Event
We invite you to join a discussion about the management of FLT3-mutated AML and what’s new in 2026. The discussion will cover the impact of newly available Quizartinib on Canadian practice, and recent advances in FLT3-ITD MRD testing.